Millrace Asset Group, Inc. Oncocyte Corp Transaction History

Millrace Asset Group, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$2.04 - $3.59 $1.25 Million - $2.2 Million	-613,885 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$3.53 - $5.89 $970,601 - $1.62 Million	274,958 Added 81.13%	613,885 $2.19 Million
Q2 2021 Aug 11, 2021	BUY	$3.77 - $6.0 $418,043 - $665,322	110,887 Added 48.63%	338,927 $1.95 Million
Q1 2021 May 12, 2021	BUY	$2.39 - $6.5 $545,015 - $1.48 Million	228,040 New	228,040 $1.18 Million

399K

Ticker OCX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,609,000
Market Cap $266M
Description
OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay....

Get notified when there are updates to the investment portfolio of Millrace Asset Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Millrace Asset Group, Inc. with notifications on news.